Antares Pharma Inc (NASDAQ:ATRS)

2.53
Delayed Data
As of 4:00pm ET
 +0.01 / +0.40%
Today’s Change
1.58
Today|||52-Week Range
4.09
+27.14%
Year-to-Date

Stock Price Forecast

The 5 analysts offering 12-month price forecasts for Antares Pharma Inc have a median target of 3.85, with a high estimate of 5.00 and a low estimate of 3.00. The median estimate represents a +52.17% increase from the last price of 2.53.

Analyst Recommendations

The current consensus among 5 polled investment analysts is to Buy stock in Antares Pharma Inc. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.02
Sales
$14.0M
Reporting Date
Aug 07

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 45.00%
 
 
 
 
 
 
Growthannually 32.73%
 
 
 
 
 
 

Sales

Growthquarterly 10.05%
 
 
 
 
 
 
Growthannually 13.33%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.